Follow The Filings

AARD Aardvark Therapeutics

Aardvark Therapeutics earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by AARD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AARD insider trades
  • $145K bought by 2 insiders
  • None no sales outside a trading plan
  • $395K sold by 1 insider under 10b5-1 plans
  1. Nelson Sun See Remarks
    Planned sale
    $395K 76,754 shares at $5.15 68% of stake
    Traded Sep 10–11 Filed Sep 11
    ↗
  2. Nelson Sun CFO
    Buy
    $43K 3,000 shares at $14.40 +2.8% to stake
    Traded Dec 11, 2025 Filed Dec 12, 2025
    ↗
  3. Tien-Li Lee CEO
    Buy
    $101K 7,000 shares at $14.49 +0.5% to stake
    Traded Dec 11, 2025 Filed Dec 12, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 2 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.